CAP TODAY/Blueprint Medicines Webinar: Virtual Roundtable: Optimizing Testing for the Diagnosis of Systemic Mastocytosis

Description

Virtual Roundtable: Optimizing
Testing for the Diagnosis of
Systemic Mastocytosis

Why should you register now for this webinar?

Learn what Systemic Mastocytosis (SM) is and how the panelists use guidelines to screen for the disease
Discuss the barriers and possible solutions to screening for, and diagnosing SM
Provide recommendations that will empower cross-functional laboratory stakeholders to implement changes that can help improve the diagnosis of SM

Brought to you by CAP TODAY
Moderated by Bob McGonnagle, Publisher, CAP TODAY
Presenters: Robyn Scherber, MD, MPH, Anton Rets, MD PhD, Nathan A. Boggs, MD, PhD
You will have the opportunity to ask questions of our distinguished presenters.

CAP TODAY does not endorse any of the products or services named within. The webinar is non-accredited
promotional activity made possible by a sponsorship from Blueprint Medicines. Content and material for this speaker program have been developed by Blueprint Medicines.

Blueprint Medicines and associated logos are
trademarks of Blueprint Medicines Corporation.
All other trademarks are the property of their
respective owners.
© 2024 Blueprint Medicines Corporation
04/2024 USOTH23.0013.1

Contributors

Robyn Scherber, MD, MPH

Hematologist UT Health SA
Medical Director Blueprint Medicines
Anton Rets, MD, PhD

Associate Professor University of Utah, Medical Director Hematopathology and Immunohistochemistry
Nathan A. Boggs, MD, PhD

Assistant Professor of Medicine,
Uniformed Services University
Allergy Division Director
Bob McGonnagle

Publisher, CAP TODAY

Description

Contributors

Robyn Scherber, MD, MPH

Anton Rets, MD, PhD

Nathan A. Boggs, MD, PhD

Bob McGonnagle